$SSII Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
https://www.globenewswire.com/en/news-release...ystem.html
FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra Surgical Robotic System (the “SSi Mantra”).
The significance of the 2,000 surgeries extends beyond mere numbers; it embodies a critical response to a pressing need in the medical community. As global disparities in healthcare persist, SS Innovations has emerged as a leader in providing advanced surgical solutions that are accessible to all. The Company’s guiding principles of “democratizing access” and “decentralizing excellence” reflect its dedication to making world-class healthcare attainable for every patient, irrespective of their socio-economic background.
The SSi Mantra’s impact is already being felt in hospitals throughout India where it has been installed. Surgeons have praised its ergonomic design and precise controls, which facilitate minimally invasive procedures and improve patient outcomes. By minimizing recovery time and reducing the risk of complications, the SSi Mantra has become an invaluable tool in surgical suites, particularly in resource-constrained environments where access to advanced technologies has historically been limited due to the relative exorbitant cost associated with such technology.
Notably, the SSi Mantra has also been installed in many Tier 2 and Tier 3 cities across India, including Moradabad, Hisar, Coimbatore, Rohtak, and Cuttack, where communities are now reaping the benefits of innovative surgical technologies. Furthermore, the SSi Mantra also marks a significant milestone as Nepal’s first surgical robot, bringing renewed hope for advanced medical care to that nation.
Among the 2,000 surgeries performed, 123 were cardiac cases. Each procedure addresses varying complexities, highlighting the system’s versatility and adaptability in handling intricate surgical procedures.
To celebrate this milestone, SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava expressed his gratitude to the entire team. “It is the spirit of our engineers, their faith in the system, and their commitment to improving lives that has brought us this far”.
Dr. Vishwa Srivastava, President and COO of SS Innovations, remarked, “Our mission as a digital healthcare company is to democratize global access to the latest technologies. This milestone underscores the impact of our innovations and drives us forward in our journey to improve surgical outcomes globally.”
The success of the SSi Mantra Surgical Robotic System in India has resulted in robust quality and safety data as well as clinical patient-centric outcomes. This should be helpful in not only continuing SS Innovation’s mission to provide quality care to patients across the globe but also of value in seeking further regulatory approval in other markets.
https://www.globenewswire.com/en/news-release...ystem.html
FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra Surgical Robotic System (the “SSi Mantra”).
The significance of the 2,000 surgeries extends beyond mere numbers; it embodies a critical response to a pressing need in the medical community. As global disparities in healthcare persist, SS Innovations has emerged as a leader in providing advanced surgical solutions that are accessible to all. The Company’s guiding principles of “democratizing access” and “decentralizing excellence” reflect its dedication to making world-class healthcare attainable for every patient, irrespective of their socio-economic background.
The SSi Mantra’s impact is already being felt in hospitals throughout India where it has been installed. Surgeons have praised its ergonomic design and precise controls, which facilitate minimally invasive procedures and improve patient outcomes. By minimizing recovery time and reducing the risk of complications, the SSi Mantra has become an invaluable tool in surgical suites, particularly in resource-constrained environments where access to advanced technologies has historically been limited due to the relative exorbitant cost associated with such technology.
Notably, the SSi Mantra has also been installed in many Tier 2 and Tier 3 cities across India, including Moradabad, Hisar, Coimbatore, Rohtak, and Cuttack, where communities are now reaping the benefits of innovative surgical technologies. Furthermore, the SSi Mantra also marks a significant milestone as Nepal’s first surgical robot, bringing renewed hope for advanced medical care to that nation.
Among the 2,000 surgeries performed, 123 were cardiac cases. Each procedure addresses varying complexities, highlighting the system’s versatility and adaptability in handling intricate surgical procedures.
To celebrate this milestone, SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava expressed his gratitude to the entire team. “It is the spirit of our engineers, their faith in the system, and their commitment to improving lives that has brought us this far”.
Dr. Vishwa Srivastava, President and COO of SS Innovations, remarked, “Our mission as a digital healthcare company is to democratize global access to the latest technologies. This milestone underscores the impact of our innovations and drives us forward in our journey to improve surgical outcomes globally.”
The success of the SSi Mantra Surgical Robotic System in India has resulted in robust quality and safety data as well as clinical patient-centric outcomes. This should be helpful in not only continuing SS Innovation’s mission to provide quality care to patients across the globe but also of value in seeking further regulatory approval in other markets.
